Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate

Blood Adv. 2018 Nov 13;2(21):2917-2921. doi: 10.1182/bloodadvances.2018024430.

Pavan K Bendapudi^{1

2

3}, Alissa Robbins⁴, Nicole LeBoeuf^{3

5}, Olga Pozdnyakova^{3

6}, Ami Bhatt^{7

8}, Fujiko Duke⁴, Ryan Sells^{3

5}, John McQuiston⁹, Ben Humrighouse⁹, Betty Rouaisnel⁴, Meaghan Colling^{1

3}, Kathryn E Stephenson^{3

10

11}, Arturo Saavedra¹², Julie-Aurore Losman^{3

4

13

14}

¹ Division of Hematology and Blood Transfusion Service, Massachusetts General Hospital, Boston, MA.
² Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, MA.
³ Harvard Medical School, Boston, MA.
⁴ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
⁵ Department of Dermatology and.
⁶ Department of Pathology, Brigham and Women's Hospital, Boston, MA.
⁷ Hematology and Bone Marrow Transplantation Unit, Department of Medicine, and.
⁸ Department of Genetics, Stanford University, Stanford, CA.
⁹ Centers for Disease Control and Prevention, Atlanta, GA.
¹⁰ Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA.
¹¹ Ragon Institute of MGH, MIT, and Harvard, Boston, MA.
¹² Department of Dermatology, University of Virginia Health System, Charlottesville, VA.
¹³ Broad Institute, Cambridge, MA; and.
¹⁴ Division of Hematology, Brigham and Women's Hospital, Boston, MA.

No abstract available

Publication types